FindMyRecallSubscribe
Class I: serious health riskTerminated

Shire Human Genetic Therapies Vpriv¿ Recall

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only

Shire Human Genetic Therapies, Inc. · Lexington, MA

Risk level
Class I
Reported by FDA
Apr 30, 2014
Recall ID
D-1251-2014
Check your lot numberHow we source this data

Summary

Shire Human Genetic Therapies recalled Vpriv¿ starting Mar 14, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1251-2014 on Apr 30, 2014. Reason: Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate. Status: Terminated.

Why it was recalled

Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

Product description

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Lot numbers, UPCs & expiration codes

US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.

Where it was sold

US Nationwide including Puerto Rico; Mexico, Columbia

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1251-2014
Classification
Class I
Status
Terminated
Recall initiated
Mar 14, 2014
FDA report date
Apr 30, 2014
Quantity
8359 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Shire Human Genetic Therapies, Inc.

Original FDA data

Every field from FDA enforcement report D-1251-2014, exactly as published.

Show all FDA fields
City
Lexington
State
MA
Status
Terminated
Country
United States
Event ID
67690
Address
300-400 Shire Way
Code information
US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.
Postal code
02421-2101
Report date
Apr 30, 2014
Product type
Drugs
Recall number
D-1251-2014
Classification
Class I
Recalling firm
Shire Human Genetic Therapies, Inc.
Product quantity
8359 vials
Termination date
Aug 31, 2016
Reason for recall
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Voluntary / mandated
Voluntary: Firm initiated
Product description
VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.
Distribution pattern
US Nationwide including Puerto Rico; Mexico, Columbia
Recall initiation date
Mar 14, 2014
Initial firm notification
Letter
Center classification date
Apr 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1251-2014, published Apr 30, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls